Switch View
© Globe Newswire
19.08.2025
ISIN: US09075X1081
Biodesix Inc
BDSX
LISTED
NASDAQ
Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics
News Preview
Biodesix recently validated Thermo Fisher’s tissue-based Oncomine Dx Express Test for solid tumors on the Genexus Dx Integrated Sequencer Biodesix recently validated Thermo Fisher’s tissue-based Oncomine Dx Express Test for solid tumors on the Genexus Dx Integrated Sequencer...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: DK0060448595
Coloplast A/S
COLO B
LISTED
CPH
Coloplast A/S – Updated presenters list for Capital Markets Day on 2 September 2025
News Preview
Following the changes to the Executive Leadership Team, announced on 19.08.2025*, we are pleased to share with you the updated presenters list for our Capital Markets Day on 2 September 2025. For those of you who have signed up, we look forward to seeing you at the event. ...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US98887Q1040
Zai Lab Limited
ZLAB
LISTED
NASDAQ
Zai Lab Announces China National Medical Products Administration Grants Innovative Medical Device Designation for Tumor Treating Fields for Patients with Pancreatic Cancer
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the China National Medical Products Administration (NMPA) has granted Innovative Medical Device Designation for Tumor Treating Fields (TTFields) for patients with pancreatic cancer based on the positive results from the Phase 3 PANOVA-3 trial. The Innovative Medical Device Designation...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
19.08.2025
ISIN: US92686J1060
Viking Therapeutics Inc
VKTX
LISTED
NASDAQ
Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity
News Preview
Study Achieves Primary and Secondary Endpoints, Demonstrating Statistically Significant Reductions in Body Weight with Once-Daily VK2735 Dosing as Compared to Placebo
Up to 12.2% (26.6 lbs) Mean Weight Loss Observed After 13 Weeks of VK2735 Treatment Compared with 1.3% (2.9 lbs) for Placebo
Exploratory Assessment of Low Dose Maintenance Treatmen...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
19.08.2025
ISIN: US01438T1060
Aldeyra Therapeutics Inc
ALDX
LISTED
NASDAQ
Aldeyra Therapeutics Receives Fast Track Designation for ADX‑2191 for the Treatment of Retinitis Pigmentosa
News Preview
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation for ADX-2191 (methotrexate intravitreal injection, USP) for the treatment of retinitis pigmentosa. There is currently no approved treatment for patients with most forms of retinitis pigmentosa, a c...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US30050B1017
Evolent Health Inc
EVH
LISTED
NYSE
Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock
News Preview
WASHINGTON, Aug. 19, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions ("Evolent"), today announced the pricing of $145.0 million aggregate principal amount of 4.50% convertible senior notes due 2031. The notes are being offered only to persons reasonabl...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: CA13509T1057
MTL Cannabis Corp.
MTLC
LISTED
CSE
MTL Cannabis Corp. Announces up to $4 Million Brokered LIFE Offering Led by Centurion One Capital
News Preview
/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
PICKERING, ON, Aug. 19, 2025 /CNW/ - MTL Cannabis Corp. ("MTL Cannabis" or the "Company") (CSE: MTLC) (OTCQX: MTLNF) is pleased to announce that it has entered into an agreement with Centurion One Capital Corp. (the "Lead Agent" or "C1C") as lead...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US64051A1016
NeOnc Technologies Holdings Inc
NTHI
LISTED
NASDAQ
NeOnc Technologies Holdings Reports Second Quarter 2025 Results and Provides Operational Update
News Preview
CALABASAS, Calif. and ABU DHABI, United Arab Emirates, Aug. 19, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a multi–Phase 2 clinical-stage biotechnology company pioneering therapies for central nervous system (CNS) cancers, today announced financial results for the quarter ended June 30, 2025, and provided an update...
Themefolio
Profiler
Peergroup
© Newsfile
19.08.2025
ISIN: CA74141E1043
PreveCeutical Medical Inc.
PREV
LISTED
CSE
BioGene Therapeutics Inc. Appoints Dr. Kamal Albarazanji as Senior Director of Metabolic Research
News Preview
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce that its wholly...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
Medtronic announces Board appointments and shareholder value creation initiatives to advance strategic priorities
News Preview
Experienced executives John Groetelaars and Bill Jellison appointed to the Board of Directors
Board forms new Growth and Operating committees to sharpen focus on the company's ongoing strategic portfolio management, operational execution and capital allocation
Plan to host Investor Day in 2026
Initiatives follow constructive engagement with Ellio...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
Medtronic announces Board appointments and shareholder value creation initiatives to advance strategic priorities
News Preview
Experienced executives John Groetelaars and Bill Jellison appointed to the Board of Directors
Board forms new Growth and Operating committees to sharpen focus on the company's ongoing strategic portfolio management, operational execution and capital allocation
Plan to host Investor Day in 2026
Initiatives follow constructive engagement with Ellio...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
Medtronic reports first quarter fiscal 2026 financial results
News Preview
11th quarter in a row of mid-single digit organic revenue growth;Poised to accelerate growth
GALWAY, Ireland, Aug. 19, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its first quarter (Q1) of fiscal year 2026 (FY26), which ended July 25, 2025....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
19.08.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
Medtronic reports first quarter fiscal 2026 financial results
News Preview
11th quarter in a row of mid-single digit organic revenue growth;
Poised to accelerate growth
GALWAY, Ireland, Aug. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its first quarter (Q1) of fiscal year 2026 (FY26), which ended July 25, 2025.
Key Highlights...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Vets and Pet-Owners See Gaps in Flea and Tick Prevention, Highlighting Need for Year-Round Care, New Merck Animal Health Global Survey Finds
News Preview
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced results from a new global survey revealing significant gaps in pet owner adherence to flea and tick prevention and concerns among veterinarians, underscoring the need for year-r...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US92859E1082
Vivos Therapeutics Inc.
VVOS
LISTED
NASDAQ
Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call
News Preview
Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US74346N4043
Propanc Biopharma, Inc.
PPCB
LISTED
OTC
Propanc Biopharma Announces Closing of Public Offering and Uplisting to NASDAQ
News Preview
Propanc Biopharma closes an underwritten public offering of 1,000,000 shares of its common stock at a price of $4.00 per share...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US74051N1028
Premier Inc
PINC
LISTED
NASDAQ
Premier, Inc. Reports Fiscal-Year 2025 Fourth-Quarter and Full-Year Financial Results
News Preview
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2025 fourth quarter and full year ended June 30, 2025.
Fiscal-year 2025 fourth quarter total net revenue of $262.9 million decreased 12% from the prior-year period; however, increased 1% on a sequential b...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US8064071025
Henry Schein Inc
HSIC
LISTED
NASDAQ
Henry Schein’s 28th Annual ‘Back to School’ Program Supports Students Worldwide
News Preview
For the 28th consecutive year, Henry Schein, Inc. (Nasdaq: HSIC) is helping students worldwide start the academic year off right through its “Back to School” program, a flagship initiative of Henry Schein Cares, the Company’s global corporate citizenship program. Team Schein Members (TSMs) at 45 locations in the U.S., Canada, Italy, Spain, the U.K...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US82711P2011
Silo Pharma, Inc.
SILO
LISTED
NASDAQ
Silo Pharma’s PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway
News Preview
SPC-15’s intranasal spray formulation meets safety standards for clinical trial development...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US45107K1025
iBio Inc
IBIO
LISTED
NASDAQ
iBio Announces Pricing of $50 Million Public Offering
News Preview
SAN DIEGO, Aug. 19, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq: IBIO), an AI-driven innovator of precision antibody therapies, today announced the pricing of an underwritten public offering (the “offering”) of (i) pre-funded warrants to purchase 71,540,000 shares of iBio’s common stock (the “pre-funded warrants”), and (ii) accompanying Series G...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US00887A2042
Rein Therapeutics Inc
ALRN
LISTED
NASDAQ
Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
News Preview
Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis...
Themefolio
Profiler
Peergroup
© Newsfile
19.08.2025
ISIN: US68764Y2072
OS Therapies, Inc
OSTX
LISTED
XASE
OS Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update
News Preview
U.S. FDA ("FDA") confirms OST-HER2 meets biological definition of Regenerative Medicine Advanced Therapy (RMAT) FDA issues OST-HER2 BLA number in preparation for Accelerated Approval submission following End of Phase 2 MeetingFDA End of Phase 2 Meeting scheduled for August 27, 2025 to review Phase 2b clinical trial in the prevention or delay of rec...
Themefolio
Profiler
Peergroup
© Newsfile
19.08.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Groups Heal Wellness QSR Announces the Signing of its Second Franchise Agreement for the Province of Quebec
News Preview
Toronto, Ontario--(Newsfile Corp. - August 19, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada is pleased to announce that further to its 40-unit area development agreement for the province of Quebec signed on June 18th, 2025, and t...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US45784P1012
Insulet Corp
PODD
LISTED
NASDAQ
Insulet to Participate in Upcoming Investor Conferences
News Preview
Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the upcoming investor conferences (all Eastern Time):
Wells Fargo 2025 Healthcare Conference in Boston on September 4 at 3:00 p.m.
Baird 2025 Global Healthcare Conferen...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: US30063P1057
Exact Sciences Corp
EXAS
LISTED
NASDAQ
Exact Sciences to Participate in September Investor Conferences
News Preview
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.
Wells Fargo Healthcare Conference, Boston
Fireside chat on Wednesday, September 3, 2025 at 1:30 p.m. ET
Baird...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
News Preview
Bagsværd, Denmark, 19 August 2025 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US68401U2042
OptimizeRx Corp
OPRX
LISTED
NASDAQ
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
News Preview
WALTHAM, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced organizational updates and leadership advancements designed to accelerate the Compan...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Altimmune Announces FDA Fast Track Designation for Pemvidutide in Alcohol Use Disorder (AUD)
News Preview
Pemvidutide is the only drug currently granted Fast Track Designation in AUD...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US05356F1057
Aveanna Healthcare Holdings Inc
AVAH
LISTED
NASDAQ
Aveanna to Participate at the Deutsche Bank Healthcare Summit
News Preview
ATLANTA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Deutsche Bank Healthcare Summit in New York on September 10, 2025. Management will host 1x1 investor meetings that day....
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US09075P1057
BioXcel Therapeutics, Inc.
BTAI
LISTED
NASDAQ
BioXcel Therapeutics Announces Database Lock in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
News Preview
Data from more than 2,600 agitation episodes collected...
Themefolio
Profiler
Peergroup
© EQS Newswire
19.08.2025
ISIN: FR0004056851
Valneva SE
VLA
LISTED
EURONEXT
First Berlin Equity Research GmbH: Valneva SE | Rating: Buy
News Preview
Original-Research: Valneva SE - from First Berlin Equity Research GmbH
19.08.2025 / 10:39 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain......
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US8793691069
Teleflex Inc
TFX
LISTED
NYSE
Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy
News Preview
Innovative hyaluronic acid technology delivers enhanced control and precision, significantly lowering the risk of rectal toxicity during prostate radiation treatment.1-4Initial cases have now been performed in Japan....
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: US98985Y1082
Zymeworks Inc
ZYME
LISTED
NYSE
Zymeworks Announces Participation in Upcoming Investor Conferences
News Preview
VANCOUVER, British Columbia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that m...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
19.08.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
MDCE Readies Major Share Reduction After 2,500% Q2 Revenue Surge
News Preview
MESA, ARIZONA / ACCESS Newswire / August 19, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) today provided a corporate update highlighting important operational progress and structural initiatives designed to enhance long-term shareholder value.Following its recently reported 2,500% year-over-year revenue growth in Q2 2025, the Company is pl...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
19.08.2025
ISIN: US45408X3089
IGC Pharma, Inc
IGC
LISTED
XASE
IGC Pharma Reports First Quarter Fiscal 2026 Financial Results; Company Accelerates Phase 2 Alzheimer's Trial
News Preview
POTOMAC, MARYLAND / ACCESS Newswire / August 19, 2025 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer's disease, reported its financial results for the quarter ended June 30, 2025.Highlights in the quarter include...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
19.08.2025
ISIN: US47010C4096
Jaguar Health, Inc.
JAGX
LISTED
NASDAQ
Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID)
News Preview
As announced, initial proof-of-concept results from the ongoing investigator-initiated trial in Abu Dhabi show crofelemer reduced the required total parenteral nutrition in the first participating MVID patient by up to 27%; abstract describing results accepted for presentation at upcoming North American Society for Pediatric Gastroenterology, Hepat...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Nilesh Shah joins Illumina as Head of Region, AMEA
News Preview
SINGAPORE, Aug. 19, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the appointment of Nilesh Shah as Head of Region, AMEA, effective immediately.
Nilesh brings over 25 years of leadership experience in the medical technology and life sciences industries, having h...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
19.08.2025
ISIN: US60458C1045
Mira Pharmaceuticals Inc
MIRA
LISTED
NASDAQ
MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage
News Preview
Following FDA IND clearance for neuropathic pain, the Company is preparing to initiate its U.S. Phase 2a trial in Q4 2025 MIAMI, FL / ACCESS Newswire / August 19, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel oral therapeutics for neurologic, n...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
19.08.2025
ISIN: US88066N3035
Tenon Medical, Inc.
TNON
LISTED
NASDAQ
Tenon(R) Medical Announces the Full Market Launch of the Catamaran(R) SE SI Joint Fusion System
News Preview
~Full Commercial Launch with Expanded Number of Instrument Sets and Field Support to Meet Growing Market Demand ~~ New SI Joint Fixation Device Offers a Reduced Profile in Implant Size Providing Physicians Choices for Varying Anatomy and Treatment Strategies with the Catamaran Technology ~ LOS GATOS, CA / ACCESS Newswire / August 19, 2025 / Tenon M...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Nilesh Shah joins Illumina as Head of Region, AMEA
News Preview
SINGAPORE, Aug. 19, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the appointment of Nilesh Shah as Head of Region, AMEA, effective immediately.
N...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: KYG211081248
China Medical System Holdings Ltd
867
LISTED
HKSE
CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers
News Preview
SHENZHEN, CHINA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- On 18 August, China Medical System Holdings Limited (“CMS” or the “Company”) announced its interim results for the six months ended 30 June 2025 (the “Reporting Period”), with both revenue and profit recording year-on-year growth, demonstrating the initial results of its strategic transformation....
Themefolio
Profiler
Peergroup
© EQS Newswire
19.08.2025
ISIN: CH0013396012
SKAN Group AG
SKAN
LISTED
SIX
SKAN Group mit starkem Auftragseingang im 1. Halbjahr 2025 – Guidance für Gesamtjahr bestätigt
News Preview
Ad hoc-Mitteilung gemäss Art. 53 KR
SKAN Group mit starkem Auftragseingang im 1. Halbjahr 2025 – Guidance für Gesamtjahr bestätigt
Auftragseingang steigt 20.2% auf CHF 213.0 Mio. und Auftragsbestand erreicht den Rekordwert von CHF 386.4 Mio.
Nettoerlös mit CHF 134.6 Mio. und EBITDA mit CHF 0.9 Mio. liegen aufgrund von Projektverschiebungen, welc......
Themefolio
Profiler
Peergroup
© EQS Newswire
19.08.2025
ISIN: CH0013396012
SKAN Group AG
SKAN
LISTED
SIX
SKAN Group reports strong order intake in H1 2025 – full-year guidance confirmed
News Preview
Ad hoc announcement pursuant to Art. 53 LR
SKAN Group reports strong order intake in H1 2025 – full-year guidance confirmed
Order intake rises 20.2% to CHF 213.0 million and order backlog reaches record level of CHF 386.4 million.
Net sales of CHF 134.6 million and EBITDA of CHF 0.9 million are below the previous year's levels due to project pos......
Themefolio
Profiler
Peergroup
© EQS Newswire
19.08.2025
ISIN: CH0386200239
Medartis Holding AG
MED
LISTED
SIX
Medartis erzielt im ersten Halbjahr ein organisches Umsatzwachstum von 15,3 % und erhöht die Umsatzprognose für das Gesamtjahr
News Preview
Medartis Holding AG / Schlagwort(e): Halbjahresergebnis
Medartis erzielt im ersten Halbjahr ein organisches Umsatzwachstum von 15,3 % und erhöht die Umsatzprognose für das Gesamtjahr 19.08.2025 / 06:59 CET/CEST
Veröffentlichung einer Ad-hoc-Mitteilung gemäss Art. 53 KR...
Themefolio
Profiler
Peergroup
© EQS Newswire
19.08.2025
ISIN: CH0386200239
Medartis Holding AG
MED
LISTED
SIX
Medartis delivers 15.3% organic sales growth in H1 and lifts sales guidance for the full-year
News Preview
Medartis Holding AG / Key word(s): Half Year Results
Medartis delivers 15.3% organic sales growth in H1 and lifts sales guidance for the full-year 19-Aug-2025 / 06:59 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
© EQS Newswire
19.08.2025
ISIN: DE000STRA555
Stratec Se
SBS
LISTED
XETR
STRATEC BERICHTET ERGEBNISSE ZUM ERSTEN HALBJAHR 2025
News Preview
STRATEC BERICHTET ERGEBNISSE ZUM ERSTEN HALBJAHR 2025
Konzernumsatz steigt in H1/2025 währungsbereinigt um 5,8% auf 118,6 Mio. €
(H1/2024: 112,7 Mio. €)
Bei stabiler Bruttomarge sinkt die adjustierte EBIT-Marge H1/2025 aufgrund von Währungseffekten; adjustierte EBIT-Marge H1/2025 bei 7,2% (H1/2024: 8,8%)
Deutliche Belebung der Dealpipeline im ......
Themefolio
Profiler
Peergroup
© EQS Newswire
19.08.2025
ISIN: DE000STRA555
Stratec Se
SBS
LISTED
XETR
STRATEC REPORTS RESULTS FOR FIRST HALF OF 2025
News Preview
STRATEC REPORTS RESULTS FOR FIRST HALF OF 2025
Consolidated sales at constant currency grow 5.8% to € 118.6 million in H1/2025 (H1/2024: € 112.7 million)
Gross margin remains stable, but currency items lower adjusted EBIT margin to 7.2% in H1/2025 (H1/2024: 8.8%)
Significant revival in deal pipeline in the area of system development
2025 guida......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
19.08.2025
ISIN: CA98980M1095
Zomedica Corporation
ZOM
LISTED
XASE
Zomedica and VerticalVet Announce Strategic Partnership to Deliver Advanced Veterinary Technologies to Independent Practices
News Preview
New agreement brings innovative shock wave, tPEMF therapy, monitoring, and bleeding control solutions to more than 2,200 member clinics nationwide ANN ARBOR, MI / ACCESS Newswire / August 19, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering advanced diagnostic and therapeuti...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: DK0060448595
Coloplast A/S
COLO B
LISTED
CPH
Coloplast A/S - Interim Financial Report, 9M 2024/25
News Preview
2024/25...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: DK0060448595
Coloplast A/S
COLO B
LISTED
CPH
Coloplast A/S - Announcement no. 05/2025 - Coloplast announces changes to Executive Leadership Team
News Preview
Coloplast announces changes to Executive Leadership Team...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: CH0011432447
Basilea Pharmaceutica AG Allschwil
BSLN
LISTED
SIX
Basilea on track with strong 2025 half-year results
News Preview
Ad hoc announcement pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: CH0363463438
Idorsia Ltd
IDIA
LISTED
SIX
Idorsia publishes end results of repurchase offer for its 2025 and 2028 convertible bonds
News Preview
Ad hoc announcement pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: CH0027148649
Santhera Pharmaceuticals Holding AG
SANN
LISTED
SIX
Santhera Secures Agreement with Uniphar for the Distribution of AGAMREE® (Vamorolone) in five GCC (Gulf Cooperation Council) Countries
News Preview
Pratteln, Switzerland, 19 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE® (vamorolone) in the United Arab Emirates, the Kingdom of Saudi Arabia, Kuwait, Oman and Bahrain, for the treatment of Duchenne muscular dystrophy (DMD) in patients four yea...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ISIN: CH0432492467
Alcon AG
ALC
LISTED
NYSE
Alcon Underscores Benefits of Its IOLs and Cataract Surgical Equipment at APACRS
News Preview
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced a strong presence at the 37th Asia-Pacific Association of Cataract and Refractive Surgeons (APACRS) Annual Meeting. APACRS will be held at Mahatma Mandir Convention and Exhibition Centre (MMCEC) in Ahmedabad, India from August 21-23, 2025. The company...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
HIMS Deadline: HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Aug. 18, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates in...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
ISIN: SGXZ17669631
CytoMed Therapeutics Limited
GDTC
LISTED
NASDAQ
CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program
News Preview
SINGAPORE, Aug. 18, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor blood-derived, cell-based allogeneic therapies for the affordable treatment of blood and solid cance...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US81663L2007
GeneDx Holdings Corp
WGS
LISTED
NASDAQ
Rosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
News Preview
NEW YORK, Aug. 18, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx Holdings Corp. (NASDAQ: WGS) resulting from al...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US14070B1017
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Aug. 18, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October 9, 2024 and July 10, 2025, both dates i...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US02155H2004
Altimmune Inc
ALT
LISTED
NASDAQ
Rosen Law Firm Urges Altimmune, Inc. (NASDAQ: ALT) Stockholders to Contact the Firm for Information About Their Rights
News Preview
NEW YORK, Aug. 18, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities Altimmune, Inc. (NASDAQ: ALT) between August 10, 2023 and June 25, 2025 (the "Class Period"). If you wish to serve as lead plaintiff, you must move the Court no later th...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
ISIN: US8292141053
Simulations Plus Inc
SLP
LISTED
NASDAQ
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
News Preview
NEW YORK, Aug. 18, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from a...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
